UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 1 - 50 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

The significance of a positive bladder neck margin after radical prostatectomy: The American Joint Committee on Cancer pathological stage T4 designation is not warranted - Abstract
Friday, 20 November 2009
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
read more

Beyond the Abstract - The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer, by Dominique C. van Rooijen, MSc, et al.
Thursday, 19 November 2009
BERKELEY, CA (UroToday.com) - Radiotherapy, given in 20-25 fractions over 4-5 weeks, is usually the second choice for the treatment of muscle-invasive bladder cancer, behind radical cystectomy.
Login to read more...

Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study - Abstract
Wednesday, 18 November 2009
Departments of Urology and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
read more

Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-{kappa}B and upregulation of TRAIL Receptors - Abstract
Wednesday, 18 November 2009
Departments of Urology, Cancer Biology, and Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
read more

Combinations of urine-based tumour markers in bladder cancer surveillance - Abstract
Tuesday, 17 November 2009
Department of Urology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
read more

Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months - Abstract
Tuesday, 17 November 2009
Pathology, Mayo Clinic, Phoenix, AZ.
read more

Does a pT0 cystectomy specimen imply being tumour-free in the long term? - Abstract
Tuesday, 17 November 2009
Servicio de Urología, Universidad del País Vasco, Hospital de Basurto, Bilbao, Vizcaya, España.
read more

Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients - Abstract
Monday, 16 November 2009
Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
read more

Bladder cancer in the elderly - Abstract
Friday, 13 November 2009
Division of Urology, Sidney Kimmel Center for Prostate and Urologic Cancer, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
read more

Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer - Abstract
Friday, 13 November 2009
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22908, USA.
read more

Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer - Abstract
Friday, 13 November 2009
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
read more

A novel approach to using matrix metalloproteinases for bladder cancer - Abstract
Friday, 13 November 2009
Predictive Biosciences, Inc, Lexington, Massachusetts, USA
read more

Beyond the Abstract - Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? by Devendar Katkoori, MD and Murugesan Manoharan, MD
Thursday, 12 November 2009
BERKELEY, CA (UroToday.com) - Radical cystectomy (RC) with urinary diversion in the setting of prior radiation therapy (RT) is historically associated with a higher incidence of ureterointestinal anastomotic stricture (UIAS) and anastomotic leak.
Login to read more...

Current status of robot-assisted radical cystectomy - Abstract
Thursday, 12 November 2009
Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
read more

Racial differences in treatment and outcomes among patients with early stage bladder cancer - Abstract
Wednesday, 11 November 2009
Division of Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan.
read more

Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer - Abstract
Tuesday, 10 November 2009
Division of Clinical Cancer Epidemiology, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
read more

Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: A comparative retrospective study - Abstract
Monday, 09 November 2009
Department of Urology, Sahloul University Hospital, Sousse, Tunisia.
read more

Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: Perioperative and pathologic results - Abstract
Monday, 09 November 2009
Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
read more

Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective tria - Abstract
Monday, 09 November 2009
aUOC Urologia, INT Fondazione Pascale bDipartimento di Oncologia Molecolare e Clinica, Università Federico II cClinica Urologica, Seconda Università degli Studi dUOC Urologia, Ospedale Cardarelli eUO Oncologia Medica e Terapie Innovative, INT Fondazione Pascale, Napoli fUOC Urologia, Università Magna Graecia, Catanzaro, Italy.
read more

Robotic assisted laparoscopic partial cystectomy and urachal resection for urachal adenocarcinoma - Abstract
Monday, 09 November 2009
Division of Urology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA. Philippe. Spiess@moffitt.org
read more

Beyond the Abstract - Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells, by Sensuke Konno, PhD, et al.
Friday, 06 November 2009
BERKELEY, CA (UroToday.com) - In this in vitro study, we demonstrated that growth inhibitory activity of interferon-α2b (IFN-α2b) on bladder cancer T24 cells was synergistically enhanced with maitake mushroom D-fraction (PDF), a bioactive extract.
Login to read more...

Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer - Abstract
Friday, 06 November 2009
Department of Urology, William S. Middleton Memorial Veterans Hospital, and Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.
read more

Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining - Abstract
Friday, 06 November 2009
Department of Cytopathology, Aretaieion University Hospital, Athens, Greece.
read more

The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study - Abstract
Friday, 06 November 2009
Department of Oncology, Hadassah and Hebrew University Medical Centre, P.O. Box 12000, Jerusalem 91120, Israel.
read more

The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy - Abstract
Friday, 06 November 2009
Department of Urology, University of California, Davis Medical Center, Sacramento, CA, USA.
read more

Beyond the Abstract - Laparoscopic radical cystectomy with vaginal specimen extraction: Case report, by Gonzalo Vitagliano, MD
Thursday, 05 November 2009
BERKELEY, CA (UroToday.com) - Laparsocopic radical cystectomy is still a novel procedure at our institution.
Login to read more...

Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer - Abstract
Thursday, 05 November 2009
Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, 4-9-13 Yonan, Utsunomiya, Japan.
read more

Sequence variant on 3q28 and urinary bladder cancer risk: Findings from the Los Angeles-Shanghai bladder case-control study - Abstract
Thursday, 05 November 2009
Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California;
read more

Distinct microRNA alterations characterize high- and low-grade bladder cancer - Abstract
Thursday, 05 November 2009
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom.
read more

AUA NY 2009 - Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines - Multimedia Presentation
Wednesday, 04 November 2009
SEWARD, AK, USA - Presented by Muhammad Choudhury, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Beyond the Abstract - Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? by Clive Shiff, MD and Robert W. Veltri, MD
Wednesday, 04 November 2009
BERKELEY, CA (UroToday.com) - Urinary schistosomiasis caused by the trematode parasite Schistosoma haematobium is endemic in most of Africa.
Login to read more...

The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls - Abstract
Wednesday, 04 November 2009
Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Blvd. Unit 1340, Houston, TX, 77030, USA.
read more

Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage - Abstract
Wednesday, 04 November 2009
Department of Pathology, Pitie-Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France.
read more

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance - Abstract
Wednesday, 04 November 2009
Oncologica Operative Unit "S. Giovanni di Dio" Hospital, ASL Napoli3 Frattaminore; Department of Biochemistry and Biophysics, Second University of Naples, Via Costantinopoli; Unit of Urology, "Santa Maria La Pietà" Hospital, Casoria, Naples; and the Campus Biomedico University, Section of Oncology, Rome, Italy.
read more

Predictive Biosciences announces publication in Journal of Urology of results from a pilot study of its non-invasive assay to monitor patients for bladder cancer
Tuesday, 03 November 2009
LEXINGTON, MA, USA (Press Release) - November 3, 2009
read more

Therapeutic management of de novo urological malignancy in renal transplant recipients - Abstract
Tuesday, 03 November 2009
Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, 33000, Bordeaux, France.
read more

Beyond the Abstract - Fibrin clot inhibitor medication and efficacy of Bacillus Calmette-Guerin for bladder urothelial cancer, by Stephen Boorjian, MD
Friday, 30 October 2009
BERKELEY, CA (UroToday.com) - Intravesical BCG is an immunotherapy that, together with endoscopic resection, represents the current gold standard treatment for patients with high risk non-muscle invasive urothelial carcinoma.
Login to read more...

Editorial - Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?
Friday, 30 October 2009
BERKELEY, CA (UroToday.com) - In the online edition of the British Journal of Urology, the Department of Urology at the University of Miami reported on the impact of prior pelvic radiotherapy (XRT) on the occurrence of uretero-intestinal anastomosis (UIA) stricture at subsequent urinary diversion.
Login to read more...

BJUI Mini Reviews - Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract
Thursday, 29 October 2009
This review discusses the environmental factors, including tobacco use and occupational exposure, involved in upper urinary tract (UUT) carcinoma.
Login to read more...

Efficacy of Bacillus Calmette-Guerin (BCG) therapy and cauterization of the tumor versus BCG therapy without cauterization for superficial bladder cancer - Abstract
Thursday, 29 October 2009
Guilan University of Medical Sciences, Urology Research Center, Razi Hospital, Sardare Jangal Street, Rasht, Guilan 41448, Iran.
read more

Simultaneous penile and signet ring cell bladder carcinoma in renal transplant recipient: a first case - Abstract
Tuesday, 27 October 2009
Department of Surgery, Universityof Pisa, Italy.
read more

Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer - Abstract
Tuesday, 27 October 2009
Urologic Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center, Goyang, Korea.
read more

Upper urinary tract recurrence after radical cystectomy for bladder cancer-who is at risk? - Abstract
Tuesday, 27 October 2009
Department of Urology, University of Ulm, Ulm; Department of Urology, Klinikum Kassel, Kassel, Germany.
read more

The central urology multidisciplinary team - is it time to change the referral criteria? An audit of practice in a district general hospital in London - Abstract
Tuesday, 27 October 2009
All cancer patients are discussed in multidisciplinary team meetings (MDTs).
read more

Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma - Abstract
Monday, 26 October 2009
Department of Urology, Columbia University College of Physicians & Surgeons, New York, NY.
read more

What is most important is what comes across : Urological guidelines from the target group's point of view - Abstract
Monday, 26 October 2009
Klinik für Urologie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
read more

Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical Bacille Calmette-Guérin - Abstract
Monday, 26 October 2009
The Urology Centre and Department of Histopathology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
read more

Arsenic exposure predicts bladder cancer survival in a US population - Abstract
Monday, 26 October 2009
Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, Norris Cotton Cancer Center, Dartmouth Medical School, 7927 Rubin 860 One Medical Center Drive, Lebanon, NH, 03756, USA.
read more

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia - Abstract
Monday, 26 October 2009
Department of Radiooncology, University of Erlangen, Germany.
read more

Glucocorticoid therapy and risk of bladder cancer - Abstract
Monday, 26 October 2009
Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH 03756, USA
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts